文献速递新生儿

全国质量改进协作降低新生儿黄疸亚阈值光疗

A National Quality Improvement Collaborative to Reduce Subthreshold Phototherapy for Jaundice.
PubMed 文献 · Pediatrics · 2026-01-01

该质量改进协作纳入北美146家医院,分析33 384例次胎龄≥35周新生儿住院光疗 encounters,比较2022年指南前基线期与2023年干预期。亚阈值胆红素启动光疗比例从48.2%降至41.1%,未达到≤10%的目标;总体光疗 encounters 相对减少33.3%,但需升级护理比例和峰值胆红素>25 mg/dL比例略有上升。

要点

  • 亚阈值光疗比例从48.2%降至41.1%,未达≤10%目标
  • 总体光疗 encounters 相对减少33.3%,每中心每月中位数从12降至8
  • 需升级护理比例从5.73%升至6.32%,峰值胆红素>25 mg/dL从0.87%升至2.12%

核心结论

  • 亚阈值光疗减少但未达到将亚阈值 encounters 降至所有光疗 encounters 10%或以下的目标。

研究设计与样本

  • 质量改进协作纳入北美146家医院,分析119个站点33 384例次胎龄≥35周新生儿住院光疗 encounters。
  • 基线期为2022年2月至2023年1月(含6个月指南前和6个月洗脱期),干预期为2023年2月至2024年1月。
  • 干预包括质量改进辅导、教育网络研讨会、电子健康记录工具、临床算法和沟通资源。
  • 主要结局采用中断时间序列分析,平衡指标采用统计过程控制。

主要发现

  • 亚阈值胆红素启动光疗比例从指南前基线期48.2%降至干预结束时41.1%。
  • 总体光疗 encounters 相对减少33.3%,每站点每月中位数从基线期12降至干预结束时8。
  • 需升级护理阈值 encounters 比例从5.73%升至6.32%,峰值胆红素>25 mg/dL比例从0.87%升至2.12%。

关键数值与推荐

  • 目标为12个月内将住院亚阈值光疗 encounters 降至所有光疗 encounters 的10%。
  • 亚阈值光疗比例从48.2%降至41.1%,未达到≤10%的目标。

临床怎么用

  • 可参考多组分质量改进策略减少亚阈值光疗,但需关注未达目标及平衡指标变化。
  • 实施中应监测需升级护理比例和峰值胆红素>25 mg/dL比例,避免延误必要治疗。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Subthreshold phototherapy use is common in infants with hyperbilirubinemia but leads to overtreatment of safe bilirubin levels. Coincident with publication of the 2022 American Academy of Pediatrics neonatal hyperbilirubinemia guidelines, we formed a quality improvement (QI) collaborative with the aim to reduce inpatient subthreshold phototherapy use to 10% of all phototherapy encounters over 12 months. METHODS: Our QI collaborative included 146 hospitals across North America. Sites submitted data from inpatient phototherapy encounters of newborns born at 35 weeks' gestation or more between February 2022-January 2023 (baseline period; 6-month preguideline period, 6-month washout period) and February 2023-January 2024 (intervention period). Interventions included QI coaching, educational webinars, electronic health record tools, clinical algorithms, and communication resources. We analyzed the primary outcome with interrupted time series and balancing measures by statistical process control. RESULTS: Final analysis included 33 384 phototherapy encounters (20 018 baseline, 13 366 intervention) from 119 sites. The percentage of encounters initiated at subthreshold bilirubin levels decreased from 48.2% in the preguideline baseline period to 41.1% at the end of intervention. Overall phototherapy encounters demonstrated a relative decrease of 33.3%, with median encounters per site per month declining from 12 during the baseline period to 8 at the end of intervention. Modest increases were seen in percentage of encounters that met escalation-of-care threshold (5.73%-6.32%) and peak bilirubin greater than 25 mg/dL (0.87%-2.12%). CONCLUSIONS: Although subthreshold phototherapy decreased, the chosen goal of reducing subthreshold encounters to 10% or less of all phototherapy encounters was not reached after 12 months. Future work is needed to determine barriers to reducing unnecessary treatment for neonatal jaundice.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Satrom KM, Kerns E, Schissel M, et al. A National Quality Improvement Collaborative to Reduce Subthreshold Phototherapy for Jaundice. Pediatrics. 2026. PMID: 42235950. doi:10.1542/peds.2025-071494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。